(Circulation. 2002;105:54.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif.
Correspondence to Karlman Wasserman, MD, PhD, the Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90509-2910. E-mail kwasserm{at}ucla.edu
Background Because of high pulmonary vascular resistance in patients with primary pulmonary hypertension (PPH), right atrial pressure may exceed left atrial pressure during exercise, resulting in a right-to-left shunt via a patent foramen ovale (PFO). This shunting would disturb arterial PCO2 and H+ homeostasis if the pulmonary blood were not simultaneously hyperventilated to compensate for the high CO2 and H+ in the shunted blood. This article first hypothesizes and then describes unique changes in gas exchange when right-to-left exercise-induced shunting (EIS) occurs.
Methods and Results Retrospectively, the cardiopulmonary exercise tests of 71 PPH patients were studied. Criteria postulated to document hyperventilation of the pulmonary blood flow due to a right-to-left EIS were (1) an abrupt and sustained increase in end-tidal O2 with a simultaneous sustained decrease in end-tidal CO2; (2) an abrupt and sustained increase in the respiratory exchange ratio; and (3) usually, an associated decline in pulse oximetry saturation. Each patient was evaluated for a PFO with resting echocardiography. The investigators interpreting the gas exchange evidence of EIS were blinded to the echocardiographic readings. Forty-five percent of the patients had demonstrable EIS by gas exchange criteria. Almost all were also positive for a PFO by echocardiography. Using the resting echocardiograph as the reference, the sensitivity, specificity, positive and negative predictive values, and accuracy were all between 90% to 96%.
Conclusions Exercise-induced right-to-left shunting can be detected by noninvasive, cardiopulmonary exercise testing in patients with PPH.
Key Words: shunts echocardiography exercise hypertension, pulmonary
This article has been cited by other articles:
![]() |
M. M. Hoeper, M. W. Pletz, H. Golpon, and T. Welte Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Eur. Respir. J., May 1, 2007; 29(5): 944 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yasunobu, R. J. Oudiz, X.-G. Sun, J. E. Hansen, and K. Wasserman End-tidal PCO2 Abnormality and Exercise Limitation in Patients With Primary Pulmonary Hypertension Chest, May 1, 2005; 127(5): 1637 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hansen, X.-G. Sun, Y. Yasunobu, R. P. Garafano, G. Gates, R. J. Barst, and K. Wasserman Reproducibility of Cardiopulmonary Exercise Measurements in Patients With Pulmonary Arterial Hypertension Chest, September 1, 2004; 126(3): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hoeper, R. J. Oudiz, A. Peacock, V. F. Tapson, S. G. Haworth, A. E. Frost, and A. Torbicki End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 48S - 55S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glaser, C. F. Opitz, U. Bauer, R. Wensel, R. Ewert, P. E. Lange, and F. X. Kleber Assessment of Symptoms and Exercise Capacity in Cyanotic Patients With Congenital Heart Disease Chest, February 1, 2004; 125(2): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.M. Hoeper, N. Taha, A. Bekjarova, R. Gatzke, and E. Spiekerkoetter Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids Eur. Respir. J., August 1, 2003; 22(2): 330 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman Pulmonary function in primary pulmonary hypertension J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1028 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Sun, J. E. Hansen, N. Garatachea, T. W. Storer, and K. Wasserman Ventilatory Efficiency during Exercise in Healthy Subjects Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1443 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wensel, C. F. Opitz, S. D. Anker, J. Winkler, G. Hoffken, F. X. Kleber, R. Sharma, M. Hummel, R. Hetzer, and R. Ewert Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing Circulation, July 16, 2002; 106(3): 319 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hansen, R. Casaburi, M. S. Riley, D. P. Nicholls, K. Wasserman, K. R. Flaherty, M. M. Blaivas, J. Wald, M. Rubenfire, F. J. Martinez, et al. Mitochondrial disorders and exertional intolerance: Controversy continues Am. J. Respir. Crit. Care Med., July 1, 2002; 166(1): 118 - 120. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |